Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotic prophylaxis in nasal septal surgery
2009-018031-90Phase 3Active
- Start
- Dec 2009
- Modality
- Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of cloxacillin in surgical site infection (SSI) (2 arms). Primary endpoint: Postoperative infection within 10 days. Started Dec 2009; status: active.
02
Drugs
cloxacillin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on 2009-018031-90.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-018031-90.